FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Suspend/Revoke all Covid mRNA Vaccines: Petition

Citizens MAHA files a petition asking HHS and FDA to suspend and revoke EUAs and BLAs for mRNA Covid-19 vaccines and conduct a full safety review.

latest-news-card-1
FDA General

FDA Gladiator: Larry R. Pilot (1940-2025)

Editor Jim Dickinson posts his obituary of Larry R. Pilot (84), who co-founded FDAs first medical device bureau and parlayed his inside knowledge to b...

latest-news-card-1
Human Drugs

ICU Medical Recalls Potassium Chloride Lot

ICU Medical recalls one lot of potassium chloride injection bags packaged in cases indicating 20 mEq per bag due to a mislabeling incident.

latest-news-card-1
Human Drugs

New Endpoint Option for Alcohol Use Disorder

CDER posts a drug development qualifying tool to support treatments for alcohol use disorder products.

Biologics

Clinical Hold on Moderna Norovirus Vaccine

FDA places a clinical hold on a Phase 3 study evaluating Modernas trivalent vaccine against norovirus (mRNA-1403) after a case of Guillain-Barr syndro...

latest-news-card-1
Biologics

FDA OKs Sanofis Merilog, a Novolog Biosimilar

FDA approves Sanofi-Aventis Merilog (insulin-aspart-szjj) as a biosimilar to Novo Nordisks Novolog (insulin aspart) for improving glycemic control in ...

latest-news-card-1
Medical Devices

Abiomed Recalls Impella Heart Pumps

Abiomed recalls its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps to update their use instructions due to a risk that t...

latest-news-card-1
FDA General

Gender Statement Added to Restored FDA Pages

The Trump administration adds a gender ideology statement to two Web pages on draft guidances that FDA was ordered by a federal judge to restore earli...

Human Drugs

BMS Reports Disappointing Data in Melanoma Trial

Bristol Myers Squibb says a Phase 3 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for treating patients with completely resected stage III...

Human Drugs

More Accelerated Approval Changes Needed: Kaiser

The Kaiser Permanente healthcare system calls for FDA and congressional changes to improve the utility of the drug accelerated approval pathway.